Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 5

Hypotensive effect of alpha-lipoic acid after a single administration in rats

Pages
306–309
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, the possibility of blood pressure lowering by alphalipoic acid should be taken into account, although it does not lead to excessive orthostatic hypotension.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The effect of alpha-lipoic acid on blood pressure was investigated many times in chronic studies, but there are no studies on the effect of this compound after a single administration.
📊
Key Findings & Data:Therefore, knowledge of the potential antihypertensive effect of alpha-lipoic acid even after a single dose and possibly too much pressure reduction is interesting and useful.Methods: The mechanism of the hypotensive effect of alpha-lipoic acid was examined in normotensive rats in vivo after a single intraperitoneal administration, blood pressure in the left carotid artery of the rats was measured prior to the administration of the compounds (alphalipoic acid and/or glibenclamide) and 80 min thereafter.Results: Alpha-lipoic acid at a dosage of 50 mg/kg b.w. i.p. significantly decreased the blood pressure from the 50th min after drug administration.
💡
Conclusion & Impact:Therefore, the possibility of blood pressure lowering by alphalipoic acid should be taken into account, although it does not lead to excessive orthostatic hypotension.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The effect of alpha-lipoic acid on blood pressure was investigated many times in chronic studies, but there are no studies on the effect of this compound after a single administration. Alpha-lipoic acid is a drug used in diabetic neuropathy, often in obese patients, to treat hypertension. Therefore, knowledge of the potential antihypertensive effect of alpha-lipoic acid even after a single dose and possibly too much pressure reduction is interesting and useful.Methods: The mechanism of the hypotensive effect of alpha-lipoic acid was examined in normotensive rats in vivo after a single intraperitoneal administration, blood pressure in the left carotid artery of the rats was measured prior to the administration of the compounds (alphalipoic acid and/or glibenclamide) and 80 min thereafter.Results: Alpha-lipoic acid at a dosage of 50 mg/kg b.w. i.p. significantly decreased the blood pressure from the 50th min after drug administration. This cardiovascular effect of this compound was reversed by glibenclamide, a selective KATP blocker. Glibenclamide alone at this dose did not significantly affect the blood pressure. Statistical significance was evaluated using two-way ANOVA.Conclusion: This suggests that alpha-lipoic acid affects ATP-dependent potassium channels. It is possible that this is an indirect effect of hydrogen sulfide because alpha-lipoic acid can increase its concentration. The results obtained in this study are very important because the patients taking alpha-lipoic acid may be treated for co-existing hypertension. Therefore, the possibility of blood pressure lowering by alphalipoic acid should be taken into account, although it does not lead to excessive orthostatic hypotension.

🔖

Cite This Article

RAZNY, K. (2016). Hypotensive effect of alpha-lipoic acid after a single administration in rats. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 5, 306–309. https://ajindex.com/articles/365507

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Dinçer Y, Telci A, Kayalı R, Yılmaz İA, Çakatay U, Akçay T. Effect of lipoic acid on lipid peroxidation and anti-oxidant enzyme activities in diabetic rats. Clin Exp Pharmacol Physiol 2002; 29: 281-4
  2. Bilska A, Dudek M, Iciek M, Kwiecien I, Sokolowska-Jezewicz M, Filipek B, et al. Biological actions of lipoic acid associated with sulfane sulfur metabolism. Pharmacol Rep 2008; 60: 225-32
  3. Elsey DJ, Fowkers RC, Baxter GF. Regulation of cardiovascular cell function by hydrogen sulfide (H2S). Cell Biochem Funct 2010; 28: 95-106
  4. Wang XB, Jin HF, Tang CS, Du JB. Significance of endogenous suphur-containing gases in the cardiovascular system. Clin Exp Pharmacol Physiol 2010; 37: 745-52
  5. Beltowski J. Hydrogen sulfide as a biologically active mediator in the cardiovascular system. Postepy Hig Med Dosw 2004; 58: 285-91
  6. Al-Magableh MR, Hart JL. Mechanism of vasorelaxation and role of endogenous hydrogen sulfide production in mouse aorta. Naunyn Schmiedebergs Arch Pharmacol 2011; 383: 403-13
  7. Tang G, Wu L, Wang R. Interaction of hydrogen sulfide with ion channels. Clin Exp Pharmacol Physiol 2010; 37: 753-63
  8. Vasdev S, Gill V, Parai S, Gadag V. Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats. Mol Cell Biochem 2005; 275: 135-41
  9. Takaoka M, Kobayashi Y, Yuba M, Ohkita M, Matsumura Y. Effects of ?-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats. Eur J Pharmacol 2001; 424: 121-9
  10. Midaoui AEL, de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by ?-lipoic acid. Hypertension 2002; 39: 303-7
  11. Thirunavukkarasu V, Nandhini AT, Anuradha CV. Lipoic acid attenuates hypertension and improves insulin sensitivity, kallikrein activity and nitrite levels in high fructose-fed rats. J Comp Physiol B 2004; 174: 587-92
  12. Ergür BU, Mıcılı SÇ, Yılmaz O, Akokay P. The effects of ?-lipoic acid on aortic injury and hypertension in the rat remnant kidney (5/6 nephrectomy) model. Anatol J Cardiol 2015; 15: 000-000 [doi: 10.5152/akd.2014.5483]
  13. Zhao W, Zhang J, Lu Y, Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel opener. EMBO J 2001; 20: 6008-16
  14. Dudek M, Bilska-Wilkosz A, Knutelska J, Mogilski S, Bednarski M, Zygmunt M, et al. Are anti-inflammatory properties of lipoic acid associated with the formation of hydrogen sulfide? Pharmacol Rep 2013; 65: 1018-24
  15. Dudek M, Knutelska J, Bednarski M, Nowinski L, Zygmunt